HHV8 ORF50 antibody (AA 601-691) (AbBy Fluor® 647)
-
- Target See all HHV8 ORF50 products
- HHV8 ORF50 (Herpes Virus Type 8 ORF50 (HHV8 ORF50))
-
Binding Specificity
- AA 601-691
- Reactivity
- Human Herpesvirus 8 (HHV-8), Virus
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This HHV8 ORF50 antibody is conjugated to AbBy Fluor® 647
- Application
- Western Blotting (WB)
- Cross-Reactivity
- Virus
- Cross-Reactivity (Details)
- Human herpesvirus 8, Kaposi's sarcoma-associated herpesvirus
- Purification
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from C-terminus of HHV8 ORF50 strain GK18
- Isotype
- IgG
-
-
- Application Notes
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Expiry Date
- 12 months
-
- Target
- HHV8 ORF50 (Herpes Virus Type 8 ORF50 (HHV8 ORF50))
- Alternative Name
- HHV8 ORF50 (HHV8 ORF50 Products)
- Target Type
- Viral Protein
- Background
-
Synonyms: HHV8 ORF50, HHV 8, Human Herpes Virus 8, Human herpesvirus 8, Kaposi's sarcoma associated herpes virus, Kaposi's sarcoma associated herpesvirus, KSHV, replication and transcription activator, RTA
Background: HHV8 has been found to be associated with three different diseases observed in AIDS patients, kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.
- Gene ID
- 4961526
- UniProt
- F5HCV3
-